Ultramicrosize Griseofulvin
- Product NDC
- 23155-864
- 11-digit product format
- 231550864
- Labeler code
- 23155
- Product ID
- 23155-864_db35c070-b434-48f2-8ce8-e902d498459a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Griseofulvin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc
- Application
- ANDA061996
- Marketing category
- ANDA
- Marketing start
- 2023-06-30
- Substance
- GRISEOFULVIN
- Active strength
- 250 mg/1
- Pharmacologic classes
- Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ultramicrosize Griseofulvin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GRISEOFULVIN | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 32HRV3E3D5 |
| Rxcui | 239239, 242831 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 23155-864-01 | Ultramicrosize Griseofulvin | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 23155-864 | ULTRAMICROSIZE GRISEOFULVIN (GRISEOFULVIN) TABLET [HERITAGE PHARMACEUTICALS INC D/B/A AVET PHARMACEUTICALS INC] | 2 | Current NDC, 1 package rows | 20230908_ae369582-2e4c-48a4-ac42-0a77466654fd.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 23155-864-01 | 23155086401 | 100 TABLET in 1 BOTTLE, PLASTIC (23155-864-01) | 100 tablet | 2023-06-30 | No | No | Current |